aluates Reports

$ 0.0

Automative

Global CRISPR-associated Nucleases Market Research Report 2024

Published Date: April 2024

Report Code: QYRE-Auto-32G16881

BUY CHAPTERS

Global CRISPR-associated Nucleases Market Research Report 2024

Code: QYRE-Auto-32G16881

Report

April 2024

Pages:84

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Thermo Fisher Scientific

GenScript

Integrated DNA Technologies, Inc.

Aldevron

Merck

Horizon Discovery

Agilent

OriGene Technologies, Inc.

New England Biolabs

NIPPON GENE CO., LTD.

Novoprotein

Applied Biological Materials Inc. (abm)

CRISPR-associated Nucleases Market

Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR) systems, which form an adaptive immune system in bacteria, have been modified for genome engineering. CRISPR is a technology that can be employed to edit genes. Moreover, CRISPR technology has the potential to transform medicine and make us not only treat but also prevent many diseases.The core of CRISPR is the "Cas" proteins found in bacteria, where they help defend against viruses. CRISPR-associated (Cas) nucleases are furnishing transformative technologies for genome editing and functional genomics.

The global CRISPR-associated Nucleases market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.

The Cas9 protein is the most commonly used by scientists. They recognize their substrate sequence via a Protospacer Adjacent Motif (PAM) sequence and base-pairing of the target sequence by a guide RNA (gRNA) borne by the nuclease. Upon target recognition, Cas nucleases induce a double-strand break, following which the cell's repair machinery can be co-opted to alter the genomic sequence.

This report aims to provide a comprehensive presentation of the global market for CRISPR-associated Nucleases, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CRISPR-associated Nucleases.

The CRISPR-associated Nucleases market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global CRISPR-associated Nucleases market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the CRISPR-associated Nucleases companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of CRISPR-associated Nucleases Market Report

Report Metric	Details
Report Name	CRISPR-associated Nucleases Market
Segment by Type	Cas9 Cas12 Cas13 Others
Segment by Application	Gene Editing Cell Line Construction Animal Models Bioagriculture Gene Therapy Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Thermo Fisher Scientific, GenScript, Integrated DNA Technologies, Inc., Aldevron, Merck, Horizon Discovery, Agilent, OriGene Technologies, Inc, New England Biolabs, NIPPON GENE CO., LTD., Novoprotein, Applied Biological Materials Inc. (abm)
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CRISPR-associated Nucleases company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the CRISPR-associated Nucleases Market report?

Ans: The main players in the CRISPR-associated Nucleases Market are Thermo Fisher Scientific, GenScript, Integrated DNA Technologies, Inc., Aldevron, Merck, Horizon Discovery, Agilent, OriGene Technologies, Inc, New England Biolabs, NIPPON GENE CO., LTD., Novoprotein, Applied Biological Materials Inc. (abm)

What are the Application segmentation covered in the CRISPR-associated Nucleases Market report?

Ans: The Applications covered in the CRISPR-associated Nucleases Market report are Gene Editing Cell Line Construction, Animal Models, Bioagriculture, Gene Therapy, Other

What are the Type segmentation covered in the CRISPR-associated Nucleases Market report?

Ans: The Types covered in the CRISPR-associated Nucleases Market report are Cas9, Cas12, Cas13, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global CRISPR-associated Nucleases Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Cas9

1.2.3 Cas12

1.2.4 Cas13

1.2.5 Others

1.3 Market by Application

1.3.1 Global CRISPR-associated Nucleases Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Gene Editing Cell Line Construction

1.3.3 Animal Models

1.3.4 Bioagriculture

1.3.5 Gene Therapy

1.3.6 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global CRISPR-associated Nucleases Market Perspective (2019-2030)

2.2 Global CRISPR-associated Nucleases Growth Trends by Region

2.2.1 Global CRISPR-associated Nucleases Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 CRISPR-associated Nucleases Historic Market Size by Region (2019-2024)

2.2.3 CRISPR-associated Nucleases Forecasted Market Size by Region (2025-2030)

2.3 CRISPR-associated Nucleases Market Dynamics

2.3.1 CRISPR-associated Nucleases Industry Trends

2.3.2 CRISPR-associated Nucleases Market Drivers

2.3.3 CRISPR-associated Nucleases Market Challenges

2.3.4 CRISPR-associated Nucleases Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top CRISPR-associated Nucleases Players by Revenue

3.1.1 Global Top CRISPR-associated Nucleases Players by Revenue (2019-2024)

3.1.2 Global CRISPR-associated Nucleases Revenue Market Share by Players (2019-2024)

3.2 Global CRISPR-associated Nucleases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by CRISPR-associated Nucleases Revenue

3.4 Global CRISPR-associated Nucleases Market Concentration Ratio

3.4.1 Global CRISPR-associated Nucleases Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by CRISPR-associated Nucleases Revenue in 2023

3.5 Global Key Players of CRISPR-associated Nucleases Head office and Area Served

3.6 Global Key Players of CRISPR-associated Nucleases, Product and Application

3.7 Global Key Players of CRISPR-associated Nucleases, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 CRISPR-associated Nucleases Breakdown Data by Type

4.1 Global CRISPR-associated Nucleases Historic Market Size by Type (2019-2024)

4.2 Global CRISPR-associated Nucleases Forecasted Market Size by Type (2025-2030)

5 CRISPR-associated Nucleases Breakdown Data by Application

5.1 Global CRISPR-associated Nucleases Historic Market Size by Application (2019-2024)

5.2 Global CRISPR-associated Nucleases Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America CRISPR-associated Nucleases Market Size (2019-2030)

6.2 North America CRISPR-associated Nucleases Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America CRISPR-associated Nucleases Market Size by Country (2019-2024)

6.4 North America CRISPR-associated Nucleases Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe CRISPR-associated Nucleases Market Size (2019-2030)

7.2 Europe CRISPR-associated Nucleases Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe CRISPR-associated Nucleases Market Size by Country (2019-2024)

7.4 Europe CRISPR-associated Nucleases Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific CRISPR-associated Nucleases Market Size (2019-2030)

8.2 Asia-Pacific CRISPR-associated Nucleases Market Growth Rate by Country: 2019 VS 2023 VS 2030

8.3 Asia-Pacific CRISPR-associated Nucleases Market Size by Region (2019-2024)

8.4 Asia-Pacific CRISPR-associated Nucleases Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America CRISPR-associated Nucleases Market Size (2019-2030)

9.2 Latin America CRISPR-associated Nucleases Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America CRISPR-associated Nucleases Market Size by Country (2019-2024)

9.4 Latin America CRISPR-associated Nucleases Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa CRISPR-associated Nucleases Market Size (2019-2030)

10.2 Middle East & Africa CRISPR-associated Nucleases Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa CRISPR-associated Nucleases Market Size by Country (2019-2024)

10.4 Middle East & Africa CRISPR-associated Nucleases Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Thermo Fisher Scientific

11.1.1 Thermo Fisher Scientific Company Details

11.1.2 Thermo Fisher Scientific Business Overview

11.1.3 Thermo Fisher Scientific CRISPR-associated Nucleases Introduction

11.1.4 Thermo Fisher Scientific Revenue in CRISPR-associated Nucleases Business (2019-2024)

11.1.5 Thermo Fisher Scientific Recent Development

11.2 GenScript

11.2.1 GenScript Company Details

11.2.2 GenScript Business Overview

11.2.3 GenScript CRISPR-associated Nucleases Introduction

11.2.4 GenScript Revenue in CRISPR-associated Nucleases Business (2019-2024)

11.2.5 GenScript Recent Development

11.3 Integrated DNA Technologies, Inc.

11.3.1 Integrated DNA Technologies, Inc. Company Details

11.3.2 Integrated DNA Technologies, Inc. Business Overview

11.3.3 Integrated DNA Technologies, Inc. CRISPR-associated Nucleases Introduction

11.3.4 Integrated DNA Technologies, Inc. Revenue in CRISPR-associated Nucleases Business (2019-2024)

11.3.5 Integrated DNA Technologies, Inc. Recent Development

11.4 Aldevron

11.4.1 Aldevron Company Details

11.4.2 Aldevron Business Overview

11.4.3 Aldevron CRISPR-associated Nucleases Introduction

11.4.4 Aldevron Revenue in CRISPR-associated Nucleases Business (2019-2024)

11.4.5 Aldevron Recent Development

11.5 Merck

11.5.1 Merck Company Details

11.5.2 Merck Business Overview

11.5.3 Merck CRISPR-associated Nucleases Introduction

11.5.4 Merck Revenue in CRISPR-associated Nucleases Business (2019-2024)

11.5.5 Merck Recent Development

11.6 Horizon Discovery

11.6.1 Horizon Discovery Company Details

11.6.2 Horizon Discovery Business Overview

11.6.3 Horizon Discovery CRISPR-associated Nucleases Introduction

11.6.4 Horizon Discovery Revenue in CRISPR-associated Nucleases Business (2019-2024)

11.6.5 Horizon Discovery Recent Development

11.7 Agilent

11.7.1 Agilent Company Details

11.7.2 Agilent Business Overview

11.7.3 Agilent CRISPR-associated Nucleases Introduction

11.7.4 Agilent Revenue in CRISPR-associated Nucleases Business (2019-2024)

11.7.5 Agilent Recent Development

11.8 OriGene Technologies, Inc

11.8.1 OriGene Technologies, Inc Company Details

11.8.2 OriGene Technologies, Inc Business Overview

11.8.3 OriGene Technologies, Inc CRISPR-associated Nucleases Introduction

11.8.4 OriGene Technologies, Inc Revenue in CRISPR-associated Nucleases Business (2019-2024)

11.8.5 OriGene Technologies, Inc Recent Development

11.9 New England Biolabs

11.9.1 New England Biolabs Company Details

11.9.2 New England Biolabs Business Overview

11.9.3 New England Biolabs CRISPR-associated Nucleases Introduction

11.9.4 New England Biolabs Revenue in CRISPR-associated Nucleases Business (2019-2024)

11.9.5 New England Biolabs Recent Development

11.10 NIPPON GENE CO., LTD.

11.10.1 NIPPON GENE CO., LTD. Company Details

11.10.2 NIPPON GENE CO., LTD. Business Overview

11.10.3 NIPPON GENE CO., LTD. CRISPR-associated Nucleases Introduction

11.10.4 NIPPON GENE CO., LTD. Revenue in CRISPR-associated Nucleases Business (2019-2024)

11.10.5 NIPPON GENE CO., LTD. Recent Development

11.11 Novoprotein

11.11.1 Novoprotein Company Details

11.11.2 Novoprotein Business Overview

11.11.3 Novoprotein CRISPR-associated Nucleases Introduction

11.11.4 Novoprotein Revenue in CRISPR-associated Nucleases Business (2019-2024)

11.11.5 Novoprotein Recent Development

11.12 Applied Biological Materials Inc. (abm)

11.12.1 Applied Biological Materials Inc. (abm) Company Details

11.12.2 Applied Biological Materials Inc. (abm) Business Overview

11.12.3 Applied Biological Materials Inc. (abm) CRISPR-associated Nucleases Introduction

11.12.4 Applied Biological Materials Inc. (abm) Revenue in CRISPR-associated Nucleases Business (2019-2024)

11.12.5 Applied Biological Materials Inc. (abm) Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Thermo Fisher Scientific

GenScript

Integrated DNA Technologies, Inc.

Aldevron

Merck

Horizon Discovery

Agilent

OriGene Technologies, Inc.

New England Biolabs

NIPPON GENE CO., LTD.

Novoprotein

Applied Biological Materials Inc. (abm)

List of Tables

Table 1. Global CRISPR-associated Nucleases Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Cas9

Table 3. Key Players of Cas12

Table 4. Key Players of Cas13

Table 5. Key Players of Others

Table 6. Global CRISPR-associated Nucleases Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global CRISPR-associated Nucleases Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global CRISPR-associated Nucleases Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global CRISPR-associated Nucleases Market Share by Region (2019-2024)

Table 10. Global CRISPR-associated Nucleases Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global CRISPR-associated Nucleases Market Share by Region (2025-2030)

Table 12. CRISPR-associated Nucleases Market Trends

Table 13. CRISPR-associated Nucleases Market Drivers

Table 14. CRISPR-associated Nucleases Market Challenges

Table 15. CRISPR-associated Nucleases Market Restraints

Table 16. Global CRISPR-associated Nucleases Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global CRISPR-associated Nucleases Market Share by Players (2019-2024)

Table 18. Global Top CRISPR-associated Nucleases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR-associated Nucleases as of 2023)

Table 19. Ranking of Global Top CRISPR-associated Nucleases Companies by Revenue (US$ Million) in 2023

Table 20. Global 5 Largest Players Market Share by CRISPR-associated Nucleases Revenue (CR5 and HHI) & (2019-2024)

Table 21. Global Key Players of CRISPR-associated Nucleases, Headquarters and Area Served

Table 22. Global Key Players of CRISPR-associated Nucleases, Product and Application

Table 23. Global Key Players of CRISPR-associated Nucleases, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global CRISPR-associated Nucleases Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global CRISPR-associated Nucleases Revenue Market Share by Type (2019-2024)

Table 27. Global CRISPR-associated Nucleases Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global CRISPR-associated Nucleases Revenue Market Share by Type (2025-2030)

Table 29. Global CRISPR-associated Nucleases Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global CRISPR-associated Nucleases Revenue Market Share by Application (2019-2024)

Table 31. Global CRISPR-associated Nucleases Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global CRISPR-associated Nucleases Revenue Market Share by Application (2025-2030)

Table 33. North America CRISPR-associated Nucleases Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 34. North America CRISPR-associated Nucleases Market Size by Country (2019-2024) & (US$ Million)

Table 35. North America CRISPR-associated Nucleases Market Size by Country (2025-2030) & (US$ Million)

Table 36. Europe CRISPR-associated Nucleases Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. Europe CRISPR-associated Nucleases Market Size by Country (2019-2024) & (US$ Million)

Table 38. Europe CRISPR-associated Nucleases Market Size by Country (2025-2030) & (US$ Million)

Table 39. Asia-Pacific CRISPR-associated Nucleases Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 40. Asia-Pacific CRISPR-associated Nucleases Market Size by Region (2019-2024) & (US$ Million)

Table 41. Asia-Pacific CRISPR-associated Nucleases Market Size by Region (2025-2030) & (US$ Million)

Table 42. Latin America CRISPR-associated Nucleases Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Latin America CRISPR-associated Nucleases Market Size by Country (2019-2024) & (US$ Million)

Table 44. Latin America CRISPR-associated Nucleases Market Size by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa CRISPR-associated Nucleases Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Middle East & Africa CRISPR-associated Nucleases Market Size by Country (2019-2024) & (US$ Million)

Table 47. Middle East & Africa CRISPR-associated Nucleases Market Size by Country (2025-2030) & (US$ Million)

Table 48. Thermo Fisher Scientific Company Details

Table 49. Thermo Fisher Scientific Business Overview

Table 50. Thermo Fisher Scientific CRISPR-associated Nucleases Product

Table 51. Thermo Fisher Scientific Revenue in CRISPR-associated Nucleases Business (2019-2024) & (US$ Million)

Table 52. Thermo Fisher Scientific Recent Development

Table 53. GenScript Company Details

Table 54. GenScript Business Overview

Table 55. GenScript CRISPR-associated Nucleases Product

Table 56. GenScript Revenue in CRISPR-associated Nucleases Business (2019-2024) & (US$ Million)

Table 57. GenScript Recent Development

Table 58. Integrated DNA Technologies, Inc. Company Details

Table 59. Integrated DNA Technologies, Inc. Business Overview

Table 60. Integrated DNA Technologies, Inc. CRISPR-associated Nucleases Product

Table 61. Integrated DNA Technologies, Inc. Revenue in CRISPR-associated Nucleases Business (2019-2024) & (US$ Million)

Table 62. Integrated DNA Technologies, Inc. Recent Development

Table 63. Aldevron Company Details

Table 64. Aldevron Business Overview

Table 65. Aldevron CRISPR-associated Nucleases Product

Table 66. Aldevron Revenue in CRISPR-associated Nucleases Business (2019-2024) & (US$ Million)

Table 67. Aldevron Recent Development

Table 68. Merck Company Details

Table 69. Merck Business Overview

Table 70. Merck CRISPR-associated Nucleases Product

Table 71. Merck Revenue in CRISPR-associated Nucleases Business (2019-2024) & (US$ Million)

Table 72. Merck Recent Development

Table 73. Horizon Discovery Company Details

Table 74. Horizon Discovery Business Overview

Table 75. Horizon Discovery CRISPR-associated Nucleases Product

Table 76. Horizon Discovery Revenue in CRISPR-associated Nucleases Business (2019-2024) & (US$ Million)

Table 77. Horizon Discovery Recent Development

Table 78. Agilent Company Details

Table 79. Agilent Business Overview

Table 80. Agilent CRISPR-associated Nucleases Product

Table 81. Agilent Revenue in CRISPR-associated Nucleases Business (2019-2024) & (US$ Million)

Table 82. Agilent Recent Development

Table 83. OriGene Technologies, Inc Company Details

Table 84. OriGene Technologies, Inc Business Overview

Table 85. OriGene Technologies, Inc CRISPR-associated Nucleases Product

Table 86. OriGene Technologies, Inc Revenue in CRISPR-associated Nucleases Business (2019-2024) & (US$ Million)

Table 87. OriGene Technologies, Inc Recent Development

Table 88. New England Biolabs Company Details

Table 89. New England Biolabs Business Overview

Table 90. New England Biolabs CRISPR-associated Nucleases Product

Table 91. New England Biolabs Revenue in CRISPR-associated Nucleases Business (2019-2024) & (US$ Million)

Table 92. New England Biolabs Recent Development

Table 93. NIPPON GENE CO., LTD. Company Details

Table 94. NIPPON GENE CO., LTD. Business Overview

Table 95. NIPPON GENE CO., LTD. CRISPR-associated Nucleases Product

Table 96. NIPPON GENE CO., LTD. Revenue in CRISPR-associated Nucleases Business (2019-2024) & (US$ Million)

Table 97. NIPPON GENE CO., LTD. Recent Development

Table 98. Novoprotein Company Details

Table 99. Novoprotein Business Overview

Table 100. Novoprotein CRISPR-associated Nucleases Product

Table 101. Novoprotein Revenue in CRISPR-associated Nucleases Business (2019-2024) & (US$ Million)

Table 102. Novoprotein Recent Development

Table 103. Applied Biological Materials Inc. (abm) Company Details

Table 104. Applied Biological Materials Inc. (abm) Business Overview

Table 105. Applied Biological Materials Inc. (abm) CRISPR-associated Nucleases Product

Table 106. Applied Biological Materials Inc. (abm) Revenue in CRISPR-associated Nucleases Business (2019-2024) & (US$ Million)

Table 107. Applied Biological Materials Inc. (abm) Recent Development

Table 108. Research Programs/Design for This Report

Table 109. Key Data Information from Secondary Sources

Table 110. Key Data Information from Primary Sources

Table 111. Authors List of This Report

List of Figures

Figure 1. CRISPR-associated Nucleases Picture

Figure 2. Global CRISPR-associated Nucleases Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global CRISPR-associated Nucleases Market Share by Type: 2023 VS 2030

Figure 4. Cas9 Features

Figure 5. Cas12 Features

Figure 6. Cas13 Features

Figure 7. Others Features

Figure 8. Global CRISPR-associated Nucleases Market Size by Application (2024-2030) & (US$ Million)

Figure 9. Global CRISPR-associated Nucleases Market Share by Application: 2023 VS 2030

Figure 10. Gene Editing Cell Line Construction Case Studies

Figure 11. Animal Models Case Studies

Figure 12. Bioagriculture Case Studies

Figure 13. Gene Therapy Case Studies

Figure 14. Other Case Studies

Figure 15. CRISPR-associated Nucleases Report Years Considered

Figure 16. Global CRISPR-associated Nucleases Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 17. Global CRISPR-associated Nucleases Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 18. Global CRISPR-associated Nucleases Market Share by Region: 2023 VS 2030

Figure 19. Global CRISPR-associated Nucleases Market Share by Players in 2023

Figure 20. Global Top CRISPR-associated Nucleases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR-associated Nucleases as of 2023)

Figure 21. The Top 10 and 5 Players Market Share by CRISPR-associated Nucleases Revenue in 2023

Figure 22. North America CRISPR-associated Nucleases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. North America CRISPR-associated Nucleases Market Share by Country (2019-2030)

Figure 24. United States CRISPR-associated Nucleases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Canada CRISPR-associated Nucleases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe CRISPR-associated Nucleases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Europe CRISPR-associated Nucleases Market Share by Country (2019-2030)

Figure 28. Germany CRISPR-associated Nucleases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. France CRISPR-associated Nucleases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. U.K. CRISPR-associated Nucleases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Italy CRISPR-associated Nucleases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Russia CRISPR-associated Nucleases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Nordic Countries CRISPR-associated Nucleases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Asia-Pacific CRISPR-associated Nucleases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Asia-Pacific CRISPR-associated Nucleases Market Share by Region (2019-2030)

Figure 36. China CRISPR-associated Nucleases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Japan CRISPR-associated Nucleases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. South Korea CRISPR-associated Nucleases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Southeast Asia CRISPR-associated Nucleases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. India CRISPR-associated Nucleases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Australia CRISPR-associated Nucleases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Latin America CRISPR-associated Nucleases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Latin America CRISPR-associated Nucleases Market Share by Country (2019-2030)

Figure 44. Mexico CRISPR-associated Nucleases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Brazil CRISPR-associated Nucleases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East & Africa CRISPR-associated Nucleases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Middle East & Africa CRISPR-associated Nucleases Market Share by Country (2019-2030)

Figure 48. Turkey CRISPR-associated Nucleases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Saudi Arabia CRISPR-associated Nucleases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. UAE CRISPR-associated Nucleases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Thermo Fisher Scientific Revenue Growth Rate in CRISPR-associated Nucleases Business (2019-2024)

Figure 52. GenScript Revenue Growth Rate in CRISPR-associated Nucleases Business (2019-2024)

Figure 53. Integrated DNA Technologies, Inc. Revenue Growth Rate in CRISPR-associated Nucleases Business (2019-2024)

Figure 54. Aldevron Revenue Growth Rate in CRISPR-associated Nucleases Business (2019-2024)

Figure 55. Merck Revenue Growth Rate in CRISPR-associated Nucleases Business (2019-2024)

Figure 56. Horizon Discovery Revenue Growth Rate in CRISPR-associated Nucleases Business (2019-2024)

Figure 57. Agilent Revenue Growth Rate in CRISPR-associated Nucleases Business (2019-2024)

Figure 58. OriGene Technologies, Inc Revenue Growth Rate in CRISPR-associated Nucleases Business (2019-2024)

Figure 59. New England Biolabs Revenue Growth Rate in CRISPR-associated Nucleases Business (2019-2024)

Figure 60. NIPPON GENE CO., LTD. Revenue Growth Rate in CRISPR-associated Nucleases Business (2019-2024)

Figure 61. Novoprotein Revenue Growth Rate in CRISPR-associated Nucleases Business (2019-2024)

Figure 62. Applied Biological Materials Inc. (abm) Revenue Growth Rate in CRISPR-associated Nucleases Business (2019-2024)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

CRISPR and CRISPR Associated Cas Genes Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

CRISPR And CRISPR Associated Genes Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global CRISPR Cas Genes Market Research Report 2024

Global CRISPR Genome Editing Market Insights Forecast to 2030

CRISPR in Agriculture Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global CRISPR Based Therapeutics Market Research Report 2024

Global CRISPR Nucleases Market Research Report 2024

Global CRISPR Gene Editing Market Research Report 2024

Global CRISPR Cas9 Nuclease Market Research Report 2024

Global CRISPR Kit Market Research Report 2024

Global CRISPR Editing Platform Market Research Report 2024

Global Crisper Related Nuclease Market Research Report 2024

Global Plant Breeding and CRISPR Plants Market Insights Forecast to 2030

Prime Editing Technology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Subsea Production and Processing Systems Market Insights Forecast to 2030

Global Gene Editing Technologies Market Insights Forecast to 2030

Global CRISPR Cell Line Development Market Research Report 2024

Global Cas Nuclease Market Research Report 2025

Global Gene Editing Drug Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions